Author

Victoria J. Liu

University of Chicago

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Jacky Gomez-Villa· 1 shared John C. AlverdyiD· 1 shared Lavanya VisvabharathyiD· 1 shared Natalia L. Antonides-Jensen· 1 shared Róża K. PrzanowskaiD· 1 shared Samantha S YeeiD· 1 shared Sonia L. HernandeziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Jacky Gomez-Villa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJan 30, 2026

IL-6R blockade with tocilizumab disrupts pericyte-and tumor cell-driven IL-6/STAT3 signaling, enhancing docetaxel efficacy in ER+ breast cancer

Róża K. Przanowska, Jacky Gomez-Villa, Victoria J. Liu…·Samantha S Yee

This study shows that tocilizumab enhances docetaxel efficacy in ER+ breast cancer by blocking IL-6/STAT3 signaling driven by pericytes and tumor cells.

DOI 10.64898/2026.01.29.702661

humanproteomics

𝕏 PostBluesky